Home › Funds › Man Group plc › GILD
Man Group plc position in GILD
GILEAD SCIENCES INC · Health Care
Man Group plc reported holding 1,235,196 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$156.1M, representing 0.44% of its reported portfolio and ranking #45 among its reported holdings. Man Group plc has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Man Group plc's GILD position evolved
Man Group plc first disclosed a stake in GILD in Q3 2023 at 572,498 shares (US$42.9M). The position peaked in Q4 2025 at 1,725,112 shares, worth US$211.7M. Across 12 filings, Man Group plc increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,235,196 shares valued at US$156.1M — an increase of 557,130 shares quarter over quarter.. Notable position changes include a 116% increase in Q1 2024 (shares fell 6% over the following quarter), a 91% increase in Q1 2025 (shares were roughly flat over the following quarter), a 82% increase in Q2 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 572.50K | $42.90M | New |
| Q4 2023 | 459.35K | $37.21M | Reduce |
| Q1 2024 | 991.32K | $72.61M | Add |
| Q2 2024 | 1.19M | $81.62M | Add |
| Q3 2024 | 629.61K | $52.79M | Reduce |
| Q4 2024 | 873.18K | $80.66M | Add |
| Q1 2025 | 1.66M | $186.52M | Add |
| Q2 2025 | 1.57M | $174.62M | Reduce |
| Q3 2025 | 1.76M | $194.98M | Add |
| Q4 2025 | 1.73M | $211.74M | Reduce |
| Q1 2026 | 678.07K | $94.50M | Reduce |
| Q2 2026 | 1.24M | $156.05M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on Man Group plc
FAQ
How long has Man Group plc held GILD?
Man Group plc has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Man Group plc's current position in GILD?
As of Q2 2026, Man Group plc holds 1.24M shares of GILD (GILEAD SCIENCES INC), valued at $156.05M, representing 0.44% of its reported portfolio and ranking #45.
Has Man Group plc been buying or selling GILD?
In the latest 13F filing (Q2 2026), Man Group plc increased its position in GILD. The position peaked in Q4 2025 at 1.73M shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.